MODERATOR(S)
Leslie Ballas, MD, FASTRO - Cedars Sinai
Stanley Liauw, MD, FASTRO - University of Chicago
session DESCRIPTION
Please note: The abstracts listed below will not be presented by the authors during this session. Instead, a designated discussant will highlight and discuss key findings and takeaways from these abstracts.
Credits
| AMA PRA Category 1 Credits: | 0.50 |
| CAMPEP Credits: | 0.50 |
| MDCB Credits: | 0.50 |
Presentations
-
08:00am - 08:00am ETSpeaker: Stanley Liauw, MD, FASTRO - University of Chicago, Chicago
-
08:00am - 08:00am ET
-
08:00am - 08:00am ET
Brachytherapy Versus External Beam Dose-Escalated Boost for Intermediate-Risk Prostate Cancer: Definitive Results of the GETUG P05 Trial
Speaker: Ariane Lapierre, MD, PhD - Hospices Civils de Lyon, Pierre Benite -
08:00am - 08:00am ET
Five-Year Results of a Phase 3 Trial of Hypofractionated vs. Conventional Postprostatectomy Radiotherapy: NRG Oncology GU003
Speaker: Mark Buyyounouski, MD, MS, FASTRO - Stanford University, Stanford -
08:00am - 08:00am ET
Evaluation of PAM50 Molecular Subtypes in Post-Prostatectomy Salvage Radiotherapy: An NRG Oncology-RTOG 0534 Analysis
Speaker: Shuang Zhao, MD, MSE - UT MD Anderson Cancer Center, Houston